You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 29 KDa. Observed: 45-75 KDa, reducing conditions
Mouse
Ser25-Ala263
C-6His
50 μg, 500 μg, 1 mg, 10 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 20-40 KDa, reducing conditions
Mouse
Asn53-Ser177
C-Avi-6His
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 73.8 KDa. Observed: 90-130 KDa, reducing conditions
Human
Gly30-Asn439
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57 KDa. Observed: 90-140 KDa, reducing conditions
HIV
Met1-Glu498
C-8His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57.3 KDa. Observed: 65 KDa, reducing conditions
Human
Gln18-Gly540
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 25.4 KDa. Observed: 39-44 KDa, reducing conditions
Human
Gln29-Ala248
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 25.2 KDa. Observed: 38-59 KDa, reducing conditions
Human
His22-Asn235
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.2 KDa. Observed: 40-55 KDa, reducing conditions
Human
Lys36-Asp161
C-GST
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17 KDa. Observed: 25-35 KDa, reducing conditions
Human
Ser2732-His2871
N-8His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.7 KDa. Observed: 28-35 KDa, reducing conditions
Mouse
His20-Pro187
C-6His
500 μg, 1 mg, 10 μg, 50 μg
